Home  >  News
  Wellthy Therapeutics conducts first made-in-India ‘digital pill’ clinical trial for diabetes,   November 18, 2017
  CRF Health’s TrialMax Touch selected by leading specialty pharma company for padiatric rare disease phase II study,   November 16, 2017
  Data from landmark NIH blood pressure study supports important part of new AHA/ACC hypertension guidelines,   November 15, 2017
  New data reinforces clinical basis for switching to Sandoz biosimilar medicines,   November 15, 2017
  Novartis announces positive results from two phase III studies of brolucizumab versus aflibercept,   November 14, 2017
  NousCom announces 'preclinical data of neoantigen-based cancer vaccine in combo with Nektar Therapeutics' NKTR-214,   November 14, 2017
  Donor corneas can be safely preserved for longer period: NIH study,   November 14, 2017
  Novartis Entresto real world evidence data shows beneficial impact on quality of life in people living with heart failure,   November 13, 2017
  BMS-Pfizer alliance to unveil RWD analyses - cost, safety & comparative effectiveness findings associated with oral anticoagulants in NVAF,   November 13, 2017
  Abeona begins patient enrollment in ABO-102 phase 1/2 clinical trial in Spain,   November 13, 2017
  Bavarian Nordic begins phase 2 extension study of universal RSV vaccine,   November 13, 2017
  RedHill Biopharma completes patient enrollment in phase III study of RHB-104 for Crohn's disease,   November 13, 2017
  Study showsa Forteo reduces risk for new vertebral and clinical fractures in postmenopausal women with severe osteoporosis,   November 11, 2017
  Bristol-Myers, Five Prime to present positive data from phase 1a/1b trial evaluating cabiralizumab with opdivo in patients with advanced solid tumours at SITC meeting,   November 11, 2017
  Seattle Genetics, Astellas begin phase 1b study of enfortumab vedotin in combo with immune CPI therapies in locally advanced/metastatic urothelial cancer,   November 10, 2017
  Otonomy announces positive results from AVERTS-2 phase 3 trial of Otividex in patients with ménière's disease,   November 10, 2017
  First long-term efficacy analysis on effect of GSK’s Benlysta on rate of organ damage progression in SLE versus standard therapy alone,   November 10, 2017
  AstraZeneca to share scientific updates from CVMD portfolio at AHA 2017,   November 09, 2017
  Novartis MONALEESA-7 trial of Kisqali in advanced/metastatic breast cancer meets primary endpoint,   November 09, 2017
  Novartis presents positive data from FUTURE 5 study of Cosentyx to treat psoriatic arthritis at 2017 ACR/ARHP meeting,   November 08, 2017

Pre-Connect Congress 2017
Copyright © 2016 Saffron Media Pvt. Ltd |